GL1X · GenesisL1 explorer

MolNFT v1 · #69096 · protein

HIV protease (pr) with inhibitor tl-3 bound, and dmsos in exo site

3KFP: “HIV protease (pr) with inhibitor tl-3 bound, and dmsos in exo site”. X-ray diffraction, 1 ligand (3TL), 2 pockets (best druggability 0.50). MolNFT v1 #69096 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3KFP
Type
protein
Length
99 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
Q903N5
Ligands
3TL
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtease (EC 3.4.23.16)protein994% helix, 48% strandQ903N5

Ligands and binding sites

  • 3TL · benzyl [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-dibenzyl-8,9-dihydroxy-1,16-dimethyl-4,13-bis(1-methylethyl)-2,5,12,15,18-pentaoxo-20-phenyl-19-oxa-3,6,11,14,17-pentaazaicos-1-yl]carbamate · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains A
  • BME · Beta-mercaptoethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11630.500.7721empty
2800.310.7418empty

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 3KFP · HIV Protease (PR) with inhibitor TL-3 bound, and DMSOs in exo site · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.